Cargando…
Calcium dobesilate may alleviate diabetes-induced endothelial dysfunction and inflammation
Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease. However, the pathogenesis of DKD remains unclear, and no effective treatments for the disease are available. Thus, there is an urgent need to elucidate the pathogenic mechanisms of DKD and to develop more effective therapie...
Autores principales: | Zhou, Yijun, Yuan, Jiangzi, Qi, Chaojun, Shao, Xinghua, Mou, Shan, Ni, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779917/ https://www.ncbi.nlm.nih.gov/pubmed/29039485 http://dx.doi.org/10.3892/mmr.2017.7740 |
Ejemplares similares
-
Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose
por: Zhou, Yijun, et al.
Publicado: (2019) -
Calcium dobesilate-induced hyperpyrexia: A case report
por: Yang, Hui, et al.
Publicado: (2023) -
Calcium dobesilate alleviates renal dysfunction and inflammation by targeting nuclear factor kappa B (NF-κB) signaling in sepsis-associated acute kidney injury
por: Xie, Zhijuan, et al.
Publicado: (2022) -
Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
por: Qin, Lili, et al.
Publicado: (2017) -
Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)